Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 397, Issue 2-3, Pages 373-382Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/S0014-2999(00)00233-8
Keywords
amylin; adrenomedullin; calcitonin gene-related peptide (CGRP); calcitonin receptor-like receptor; myocardial contraction; receptor associated modifying protein (RAMP)
Categories
Ask authors/readers for more resources
Isometric contractile force were studied on isolated human myocardial trabeculae that were paced at 1.0 Hz in tissue baths. Alpha calcitonin gene-related peptide (alpha-CGRP) had a potent positive inotropic effect in most trabeculae from both the right atrium and left ventricle, and this effect was partially antagonized by the CGRP(1) receptor antagonist alpha-CGRP-(8-37) (10(-6) M). Amylin and the CGRP(2) receptor agonist [Cys(acetylmethoxy)(2.7)]CGRP had a positive inotropic effect in some trabeculae, whereas adrenomedullin had no inotropic effect. Using reverse transcriptase-polymerase chain reaction (PCR) mRNAs encoding the human calcitonin receptor-like receptor and the receptor associated modifying proteins (RAMPs) RAMP1, RAMP2, and RAMP3 were detected in human myocardial trabeculae from both the right atrium and left ventricle. In conclusion, functional CGRP(1) and CGRP(2) receptors may mediate a positive inotropic effect at both the atrial and ventricular level of the human heart, mRNAs for calcitonin receptor-like receptor and specific RAMPs further support the presence of CGRP receptors. (C) 2000 Elsevier Science B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available